MX2013008996A - Novel pharmaceutical system of biphasic delivery for treating pain and inflammation. - Google Patents

Novel pharmaceutical system of biphasic delivery for treating pain and inflammation.

Info

Publication number
MX2013008996A
MX2013008996A MX2013008996A MX2013008996A MX2013008996A MX 2013008996 A MX2013008996 A MX 2013008996A MX 2013008996 A MX2013008996 A MX 2013008996A MX 2013008996 A MX2013008996 A MX 2013008996A MX 2013008996 A MX2013008996 A MX 2013008996A
Authority
MX
Mexico
Prior art keywords
tablet
inflammation
treating pain
novel pharmaceutical
biphasic delivery
Prior art date
Application number
MX2013008996A
Other languages
Spanish (es)
Other versions
MX362435B (en
Inventor
Federico Amezcua Amezcua
Amador Covarrubias Pinedo
Original Assignee
Raam De Sahuayo S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raam De Sahuayo S A De C V Lab filed Critical Raam De Sahuayo S A De C V Lab
Priority to MX2013008996A priority Critical patent/MX362435B/en
Publication of MX2013008996A publication Critical patent/MX2013008996A/en
Priority to PCT/MX2014/000114 priority patent/WO2015016695A1/en
Publication of MX362435B publication Critical patent/MX362435B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention refers to stable pharmaceutical compositions comprising a tablet-tablet system that consists in the compression of a tablet within another tablet with a biphasic delivery system of at least an analogue of (1R, 2R)-rel-2-[(dimethylamine) methyl]-1-(3 metoxifenil) cyclohexanol (Tramadol) and/or the pharmaceutically acceptable salts thereof and/or an analogue of 2-[2,6-dichlorophenyl)amine] benzeneacetic acid carboxymethyl ester (aceclofenac) and/or the stable pharmaceutical salts thereof contained in the tablet. Said compositions are useful for the control and/or prevention and/or treatment of acute and/or chronic pain as well as the acute and/or chronic inflammation.
MX2013008996A 2013-08-02 2013-08-02 Novel pharmaceutical system of biphasic delivery for treating pain and inflammation. MX362435B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2013008996A MX362435B (en) 2013-08-02 2013-08-02 Novel pharmaceutical system of biphasic delivery for treating pain and inflammation.
PCT/MX2014/000114 WO2015016695A1 (en) 2013-08-02 2014-07-24 Novel biphasic-delivery pharmaceutical system for the treatment of pain and inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2013008996A MX362435B (en) 2013-08-02 2013-08-02 Novel pharmaceutical system of biphasic delivery for treating pain and inflammation.

Publications (2)

Publication Number Publication Date
MX2013008996A true MX2013008996A (en) 2014-03-24
MX362435B MX362435B (en) 2019-01-17

Family

ID=50935221

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013008996A MX362435B (en) 2013-08-02 2013-08-02 Novel pharmaceutical system of biphasic delivery for treating pain and inflammation.

Country Status (2)

Country Link
MX (1) MX362435B (en)
WO (1) WO2015016695A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101710792B1 (en) * 2015-07-14 2017-02-28 주식회사 유영제약 Pharmaceutical compositions comprising celecoxib and tramadol
CN110141531B (en) * 2019-06-06 2022-04-19 周大凯 Composition for wrapping active components and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101410095B (en) * 2006-03-06 2015-07-01 波曾公司 Dosage forms for administering combinations of drugs
US8765178B2 (en) * 2006-07-19 2014-07-01 Watson Laboratories, Inc. Controlled release formulations and associated methods
US20080026054A1 (en) * 2007-04-27 2008-01-31 Nectid Inc. Novel anelgesic combination
CN104958282B (en) * 2007-11-23 2018-05-29 格吕伦塔尔有限公司 Tapentadol hydrochloride composition

Also Published As

Publication number Publication date
WO2015016695A1 (en) 2015-02-05
MX362435B (en) 2019-01-17

Similar Documents

Publication Publication Date Title
AU2018201997B2 (en) Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions
EA201691454A1 (en) COMPOSITIONS OF PRIDOPIDININE MODIFIED SHIPPING
PH12021551189A1 (en) Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
JP2012193216A5 (en)
EA201270221A1 (en) TREATMENT OF CROWN DISEASE WITH LACQUINIMODE
PH12015500375A1 (en) Nep inhibitors for treating diseases characterized by atrial enlargemenet or remodeling
WO2014205229A8 (en) Use of high dose pridopidine for treating huntington's disease
AR090491A1 (en) TREATMENT OF MULTIPLE SCLEROSIS WITH A COMBINATION OF LAQUINIMOD AND DIMETILO FUMARATE
WO2011127333A3 (en) Compounds for treating disease, for administering, and for pharmaceutical compositions
WO2012048294A3 (en) Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
EP3300734A3 (en) Use of levocetirizine and montelukast in the treatment of autoimmune disorders
IN2015DN01023A (en)
AR093182A1 (en) METHOD TO TREAT OVERWEIGHT OR OBESITY
WO2015079010A3 (en) Pharmaceutical composition comprising lacosamide and levetiracetam
WO2014164285A3 (en) Use of levocetirizine and montelukast in the treatment of vasculitis
EA201501164A1 (en) SOLID PHARMACEUTICAL MEDICINE FORM
EA202090637A1 (en) WAYS OF USING DIPIVEFRIN
EP3309555A3 (en) Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation
MX2013008996A (en) Novel pharmaceutical system of biphasic delivery for treating pain and inflammation.
GR1008228B (en) Pharmaceutical composition comprising a dual reuptake inhibitor and method for the preparation thereof
MX366309B (en) Pharmaceutical composition for treating inflammation and pain.
TW201129361A (en) Methods for treating pain
NZ742382A (en) Sustained-release non-steroidal anti-inflammatory drug delivery
HRP20211309T1 (en) N,n-bis-2-mercaptoethyl isophthalamide for the treatment of parkinson's disease
AR101227A1 (en) COMBINATIONS OF A N-TIAZOLIL-4-PHENOXIBENCENOSULFONAMIDE DERIVATIVE AND A PHARMACEUTICALLY ACTIVE AGENT SELECTED FROM GABAPENTINE AND PREGABALINE TO TREAT PAIN

Legal Events

Date Code Title Description
FG Grant or registration